Yatırımcı.AI

BISTTRY12:47Live

Tab Gıda Sanayi ve Ticaret A.Ş.

TABGD Price Target 2026Tab Gıda Sanayi ve Ticaret A.Ş.

Star MarketFood, Beverage and Tobacco
193.50−0.10 (−0.05%)
Volume
TRY 24.5M
Day range
192.50 – 197.10
Previous close
193.60
Market cap
TRY 50.6B

Last updated: Source: Borsa Istanbul, 15-minute delayed

The average price target of 8 brokers for TABGD is TRY 375.90 (October 28, 2026), implying 94.26% from the last price.

Broker price targets, buy-hold-sell ratings and model portfolio status for Tab Gıda Sanayi ve Ticaret A.Ş. (TABGD). The average target is compared with the current price to derive the implied upside; the AI fair value estimate is shown for comparison.

Last updated: Source: Broker research

Analyst Consensus

Average target
375.90 TL
Median target
369.00 TL
Highest target
411.41 TL
Lowest target
350.80 TL
Upside
94.26%
Buy / Hold / Sell
8 / 0 / 0

Broker Price Targets

GedikGedikOctober 28, 2026Outperform350.8081.29%
Ak YatirimAk YatirimOctober 27, 2026Outperform361.0086.56%
İş Yatırımİş YatırımOctober 27, 2026Buy411.41112.61%
Yapı KrediYapı KrediOctober 27, 2026Buy375.0093.80%
OyakOyakOctober 27, 2026Outperform363.0087.60%
HSBCHSBCOctober 26, 2026Buy360.0086.05%
TacirlerTacirlerAugust 6, 2026Buy411.00112.40%
DenizDenizAugust 6, 2026Buy375.0093.80%
IntegralIntegralJanuary 22, 2026ÖNERİ YOK359.71—
CitiCitiJanuary 22, 2026Buy325.00—
TeraTeraJanuary 21, 2026Outperform363.30—
A1 CapitalA1 CapitalJanuary 13, 2026ÖNERİ YOK323.00—

AI Fair Value

AI fair value
222.12 TL
Upside
14.79%
Model date
July 21, 2026
Analyst price targets for all stocks

Frequently Asked Questions

8 brokers have an average target of TRY 375.90 for TABGD, with 8 buy, 0 hold and 0 sell ratings.

The highest price target for TABGD is TRY 411.41, the lowest is TRY 350.80 and the median is TRY 369.00.

Our AI fair value model estimates TRY 222.12 for TABGD, a difference of 14.79% from the current price. The model was updated on July 21, 2026. Not investment advice.

No. Price targets are opinions from broker research reports, provided for information only, not a recommendation to buy or sell.